EUCTR2005-000358-65-IT进行中（未招募）不适用
A multicentre, double-blind, two parallel groups, randomized trial over four weeks of treatment to compare the clinical efficacy and safety of Levocetirizine 5 mg oral capsules once daily in the morning vs. Desloratadine 5 mg oral capsules once daily in the morning in patients suffering from Chronic Idiopathic Urticaria CI
CB PHARMA0 个研究点开始时间: 2006年1月3日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
不适用
A multicentre, double-blind, two parallel groups, randomized trial over four weeks oftreatment to compare the clinical efficacy and safety of Levocetirizine 5 mg oral capsules once daily in the morning vs. Desloratadine 5 mg oral capsules once daily in the morning in patients suffering from Chronic Idiopathic Urticaria (CIU)MedDRA version: 8.0Level: LLTClassification code 10009159Chronic Idiopathic UrticariaEUCTR2005-000358-65-DECB Pharma S.A.816
进行中（未招募）
1 期
A multicentre, double-blind, two parallel groups, randomized trial over four weeks oftreatment to compare the clinical efficacy and safety of Levocetirizine 5 mg oral capsules once daily in the morning vs. Desloratadine 5 mg oral capsules once daily in the morning in patients suffering from Chronic Idiopathic Urticaria (CIU) - CUTEChronic Idiopathic UrticariaEUCTR2005-000358-65-ESCB S.A. Pharma Sector816
进行中（未招募）
不适用
A multicentre, double-blind, two parallel groups, randomized trial over four weeks oftreatment to compare the clinical efficacy and safety of Levocetirizine 5 mg oral capsules once daily in the morning vs. Desloratadine 5 mg oral capsules once daily in the morning in patients suffering from Chronic Idiopathic Urticaria (CIU)Chronic Idiopathic UrticariaEUCTR2005-000358-65-GBCB S.A.816
进行中（未招募）
不适用
A multicentre, double-blind, two parallel groups, randomized trial over four weeks oftreatment to compare the clinical efficacy and safety of Levocetirizine 5 mg oral capsules once daily in the morning vs. Desloratadine 5 mg oral capsules once daily in the morning in patients suffering from Chronic Idiopathic Urticaria (CIU)Chronic Idiopathic UrticariaMedDRA version: 8.0Level: LLTClassification code 10009159EUCTR2005-000358-65-BECB S.A. Pharma Sector816
撤回
2 期
A multi-center, parallel-group, double-blind, placebo-controlled single and multiple dose escalation study to assess the safety and tolerability and the pharmacokinetic properties of SAR228810 given as IV infusion or as SC injection in patients with mild to moderate Alzheimer*s Disease.10009841Alzheimer's diseaseNL-OMON36925Sanofi-aventis5